Scopus BioPharma Inc.
SCPSDelisted Mar 3, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001772028
Scopus BioPharma Inc. was delisted on Mar 3, 2023; its insiders filed their last Form 4 on Nov 26, 2021; 15 institutions reported holding it in 13F filings for Q3 2022, worth $110.6K in total; no superinvestor held it.
13F holders, Q1 2022
Institutional positions in Scopus BioPharma Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 19
- −1 vs. Q4 2021
- Shares held
- 1.01M
- −1.87M (−65.0%) vs. Q4 2021
- Total value
- $693.0K
- −$4.02M (−85.3%) vs. Q4 2021
- New holders
- 3
- 8 more added
- Sold out
- 4
- 3 more reduced
1 institution that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SCPS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 1 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 1 | $0 |
| Q4 2023 | 1 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 1 | $7.49K |
| Q3 2022 | 15 | $110.6K |
| Q2 2022 | 17 | $293.0K |
| Q1 2022 | 19 | $693.0K |
| Q4 2021 | 21 | $4.71M |
| Q3 2021 | 14 | $1.14M |
| Q2 2021 | 15 | $1.07M |
| Q1 2021 | 28 | $4.89M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Scopus BioPharma Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 364,441 | $251.0K | 0.00% | +1,400+0.4% | Added |
| Geode Capital Management, LLC | 203,805 | $140.0K | 0.00% | +137,684+208.2% | Added |
| Renaissance Technologies LLC | 112,523 | $78.0K | 0.00% | +91,623+438.4% | Added |
| M&R Capital Management Inc | 76,819 | $53.0K | 0.01% | +76,819 | New |
| Bridgeway Capital Management, LLC | 67,966 | $47.0K | 0.00% | −26,000−27.7% | Reduced |
| BlackRock Inc. | 36,675 | $25.0K | 0.00% | +17,147+87.8% | Added |
| Virtu Financial LLC | 30,229 | $21.0K | 0.00% | +15,198+101.1% | Added |
| First Manhattan Co | 25,800 | $17.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 20,729 | $14.0K | 0.00% | +829+4.2% | Added |
| Susquehanna International Group, LLP | 20,723 | $14.0K | 0.00% | +20,723 | New |
| Moors & Cabot, Inc. | 14,500 | $10.0K | 0.00% | +14,500 | New |
| Northern Trust Corp | 12,516 | $9.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 9,187 | $6.00K | 0.00% | +3,450+60.1% | Added |
| JPMorgan Chase & Co | 5,000 | $3.00K | 0.00% | 00.0% | Unchanged |
| Compagnie Lombard Odier SCmA | 4,360 | $3.00K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 2,109 | $1.00K | 0.00% | −41,903−95.2% | Reduced |
| Royal Bank of Canada | 1,000 | $1.00K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 100 | $0 | 0.00% | −4,740−97.9% | Reduced |
| Wells Fargo & Company | 82 | $0 | 0.00% | +19+30.2% | Added |
| Armistice Capital, LLC | 0 | $0 | 0.00% | −2,100,000−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −30,403−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −27,043−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −20,897−100.0% | Sold out |
| Harbour Investments, Inc. | – | – | – | – | Not filed |